Home LiteratureArticle Details
PMID: 10325923 Published · ppublish English Journal Article Review

Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.

Thorax ·Vol. 54 ·No. 2 ·1999-02-00 ·Pages 161-8

Egermayer P, Town GI, Peacock AJ

Abstract

暂无摘要

MeSH Terms
Blood Platelet Disorders/etiology Collagen Diseases/etiology Humans Hypertension, Portal/etiology Hypertension, Pulmonary/etiology Hypoxia/etiology Ketanserin/therapeutic use Malignant Carcinoid Syndrome/etiology Pulmonary Embolism/etiology Receptors, Serotonin/physiology Respiratory Distress Syndrome/etiology Serotonin/physiology Serotonin Antagonists/therapeutic use
Chemicals
Receptors, Serotonin Serotonin Antagonists Serotonin Ketanserin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Egermayer P
Canterbury Respiratory Research Group, Christchurch School of Medicine, New Zealand.
Town G I
Peacock A J
References (173)
173 references, click to expand
  1. Fluoxetin-induced pulmonary granulomatosis.
    Eur Respir J. 1996 Mar;9(3):615-7 PMID: 8730028
  2. Effects of chronic dexfenfluramine treatment on pulmonary hemodynamics in dogs.
    Am J Respir Crit Care Med. 1996 Nov;154(5):1347-50 PMID: 8912746
  3. Acute, reversible pulmonary hypertension associated with cocaine use.
    Respir Med. 1996 Mar;90(3):171-4 PMID: 8736210
  4. Comparison of ketanserin and sodium nitroprusside in patients with severe ARDS.
    Anesthesiology. 1988 Jan;68(1):152-7 PMID: 3337372
  5. Platelet-mediated pulmonary hypertension and hypoxia during pulmonary microembolism: reduction by platelet inhibition.
    Chest. 1978 Dec;74(6):648-53 PMID: 738122
  6. Cardiac manifestations in mid-gut carcinoid disease.
    Eur Heart J. 1995 Feb;16(2):263-8 PMID: 7538079
  7. Primary pulmonary hypertension. Its association with microangiopathic hemolytic anemia and thrombocytopenia.
    Arch Intern Med. 1991 Jun;151(6):1221-3 PMID: 2043024
  8. Thrombocytopenia and pulmonary hypertension in the perinatal aspiration syndromes.
    J Pediatr. 1980 Apr;96(4):727-30 PMID: 7359282
  9. Pulmonary endothelial cell injury and altered lung metabolic function. Early detection of the adult respiratory distress syndrome and possible functional significance.
    Clin Chest Med. 1990 Dec;11(4):723-36 PMID: 2268998
  10. Plasma atrial natriuretic peptide in carcinoid heart disease.
    Am J Cardiol. 1989 Apr 15;63(13):969-72 PMID: 2522730
  11. Hemodynamic responses to Pasteurella haemolytica inoculation in calves given type 2 serotonergic antagonist.
    Can J Physiol Pharmacol. 1996 May;74(5):572-9 PMID: 8884022
  12. Effects of unilateral hypoxia on neuroepithelial bodies in rabbit lungs.
    J Appl Physiol Respir Environ Exerc Physiol. 1983 Dec;55(6):1665-8 PMID: 6662755
  13. Pulmonary endocrine cells in pulmonary arterial disease.
    Arch Pathol Lab Med. 1989 Apr;113(4):337-41 PMID: 2705865
  14. Disorders of platelet function.
    Dis Mon. 1992 Aug;38(8):577-631 PMID: 1321709
  15. Cardiopulmonary effects of ketanserin infusion in human pulmonary embolism.
    Am Rev Respir Dis. 1987 Jan;135(1):114-7 PMID: 3800140
  16. Pulmonary hypertension induced in rats by monocrotaline and chronic hypoxia is reduced by p-chlorophenylalanine.
    Respiration. 1985;47(1):48-56 PMID: 3156395
  17. Role of serotonin in arteriolar thrombosis and secondary vasospasm.
    J Cardiovasc Pharmacol. 1990;16 Suppl 3:S49-53 PMID: 1369719
  18. Sustained pulmonary hypertension in surgical patients.
    Am Surg. 1993 Jun;59(6):346-9 PMID: 8507056
  19. The role of serotonin blockers in cardiac anesthesia.
    J Cardiothorac Vasc Anesth. 1994 Aug;8(4):455-62 PMID: 7948806
  20. The risk factors, incidence, and prognosis of ARDS following septicemia.
    Chest. 1983 Jan;83(1):40-2 PMID: 6848333
  21. Platelet Fc receptor. Increased expression in myeloproliferative disease.
    J Clin Invest. 1981 Apr;67(4):1064-71 PMID: 6937475
  22. Exhausted platelets in chronic obstructive pulmonary disease.
    Respiration. 1983;44(1):71-6 PMID: 6219444
  23. Coexistent pulmonary and portal hypertension: morphologic and clinical features.
    J Am Coll Cardiol. 1987 Dec;10(6):1233-8 PMID: 3680790
  24. Do indole markers predict carcinoid heart disease?
    Chest. 1986 Jul;90(1):87-9 PMID: 2424676
  25. Cardiac involvement in patients with myeloproliferative disorders.
    Am J Med. 1992 Nov;93(5):498-504 PMID: 1442851
  26. Unilateral radiation pneumonitis in sheep: physiological changes and bronchoalveolar lavage.
    J Appl Physiol (1985). 1989 Mar;66(3):1273-9 PMID: 2540144
  27. Platelet activation in patients with chronic pulmonary heart disease. Effect of dipyridamole treatment.
    Chin Med J (Engl). 1995 Feb;108(2):95-7 PMID: 7774397
  28. Elevated pulmonary artery pressure. An independent predictor of mortality.
    Chest. 1991 Jan;99(1):112-20 PMID: 1824624
  29. Serotonin and pulmonary hypertension in human septic ARDS.
    Crit Care Med. 1980 Sep;8(9):490-4 PMID: 7418423
  30. Vascular response to radiation injury in the rat lung.
    Radiat Res. 1992 Feb;129(2):139-48 PMID: 1734443
  31. The humoral factor in pulmonary embolism.
    Arch Surg. 1972 Oct;105(4):593-8 PMID: 5071165
  32. 5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis.
    J Cancer Res Clin Oncol. 1991;117(1):85-7 PMID: 1997476
  33. Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine.
    Chest. 1993 Aug;104(2):614-6 PMID: 8101799
  34. Activated platelets in paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 1995 Nov;91(3):697-702 PMID: 8555078
  35. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction.
    Circulation. 1996 Nov 1;94(9):2216-20 PMID: 8901674
  36. Foreign body granulomatosis. Clinical and immunologic findings.
    Am Rev Respir Dis. 1983 May;127(5):575-80 PMID: 6303165
  37. Adult respiratory distress syndrome. Prognosis after onset.
    Am Rev Respir Dis. 1985 Sep;132(3):472-8 PMID: 4037519
  38. Effects of nitroprusside and ketanserin upon pulmonary edema after acid injury.
    Surg Gynecol Obstet. 1988 Jun;166(6):527-34 PMID: 3375964
  39. Chronic pulmonary hypertension in sheep: temporal progression of lesions.
    J Surg Res. 1996 May;62(2):243-50 PMID: 8632646
  40. Monocrotaline pyrrole-induced pulmonary hypertension in fawn-hooded rats with platelet storage pool deficiency: 5-hydroxytryptamine uptake by isolated, perfused lungs.
    Thromb Haemost. 1983 Dec 30;50(4):844-7 PMID: 6665765
  41. 5-HT1-receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: influences of vascular endothelium and tone.
    Pulm Pharmacol. 1994 Feb;7(1):65-72 PMID: 7516208
  42. Platelet survival time in patients with hypoxemia and pulmonary hypertension.
    Circulation. 1977 Apr;55(4):660-1 PMID: 837512
  43. Primary pulmonary hypertension and fenfluramine use.
    Br Heart J. 1993 Dec;70(6):537-41 PMID: 8280518
  44. [Relation between serotonin metabolism and pulmonary hypertension in rats following administration of various anorectic drugs].
    Z Kardiol. 1973 Dec;62(12):1090-8 PMID: 4778228
  45. Pulmonary hypertension in chronic obstructive pulmonary disease. Multivariate analysis.
    Chest. 1986 Aug;90(2):185-92 PMID: 3731890
  46. Heart involvement in metastatic carcinoid disease.
    Clin Cardiol. 1986 Jan;9(1):13-9 PMID: 3943230
  47. Effect of acute hypoxia on blood serotonin in human beings and rats.
    Respiration. 1976;33(1):64-9 PMID: 1244685
  48. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina.
    N Engl J Med. 1991 Mar 7;324(10):648-54 PMID: 1994247
  49. Experimental study on monocrotaline induced pulmonary hypertensive rats. (1) Effect of long-term injection of immunosuppressant.
    Tokai J Exp Clin Med. 1981 Jan;6(1):41-8 PMID: 6789505
  50. Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat.
    Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):793-7 PMID: 1554204
  51. Effects of urapidil in patients with mild pulmonary vascular hypertension.
    Drugs. 1990;40 Suppl 4:69-70 PMID: 2092974
  52. A pharmacologic examination of receptors mediating serotonin-induced bronchoconstriction in the anesthetized guinea pig.
    J Pharmacol Exp Ther. 1991 Apr;257(1):26-34 PMID: 2019990
  53. Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats.
    Am J Physiol. 1997 Mar;272(3 Pt 2):H1173-81 PMID: 9087590
  54. Arteriospasm after ergotamine tartrate in infectious hepatitis.
    Arch Intern Med. 1966 Jul;118(1):62-4 PMID: 5940196
  55. Endothelial dysfunction in human atherosclerotic coronary arteries.
    Eur Heart J. 1993 Nov;14 Suppl I:99-103 PMID: 8293787
  56. Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.
    Drugs. 1990 Dec;40(6):903-49 PMID: 2079001
  57. A role for a new vascular enzyme in the metabolism of xenobiotic amines.
    Circ Res. 1990 Jan;66(1):249-52 PMID: 2104785
  58. Intravenous injection of talc-containing drugs intended for oral use. A cause of pulmonary granulomatosis and pulmonary hypertension.
    Am J Med. 1976 May 10;60(5):711-8 PMID: 1020758
  59. Platelet adherence to thromboemboli in relation to the pathogenesis and treatment of pulmonary embolism.
    N Engl J Med. 1966 Apr 28;274(17):953-6 PMID: 5908890
  60. Vasoreactivity in isolated perfused atherosclerotic human coronary arteries.
    Int J Tissue React. 1988;10(3):159-67 PMID: 3225133
  61. Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia.
    Lancet. 1997 Nov 1;350(9087):1267-71 PMID: 9357405
  62. Increased respiratory system resistance and bronchial smooth muscle hypertrophy in children with acute postoperative pulmonary hypertension.
    Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1347-52 PMID: 7551393
  63. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease.
    J Clin Pharmacol. 1995 Jun;35(6):541-72 PMID: 7665716
  64. Role of serotonin and serotonin antagonist on pulmonary hemodynamics and microcirculation in hemorrhagic shock.
    J Thorac Cardiovasc Surg. 1974 Jun;67(6):908-14 PMID: 4827953
  65. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin.
    Am J Med. 1990 Jul;89(1):117-20 PMID: 2368783
  66. The platelet thromboxane inhibitor, dazmegrel, does not reduce monocrotaline-induced pulmonary hypertension.
    Am Rev Respir Dis. 1986 May;133(5):789-91 PMID: 3085563
  67. [Effects of methysergide on pulmonary circulation].
    Hokkaido Igaku Zasshi. 1983 Sep;58(5):541-52 PMID: 6662487
  68. Ketanserin, a serotonin antagonist. Administration in patients with acute respiratory failure.
    Chest. 1984 Apr;85(4):510-3 PMID: 6705581
  69. Pulmonary hypertension and systemic lupus erythematosus.
    J Rheumatol. 1986 Feb;13(1):1-5 PMID: 2871187
  70. [The effects of persantine on pulmonary arterial pressure of rats exposed to hypoxia].
    Zhonghua Jie He He Hu Xi Za Zhi. 1993 Aug;16(4):216-7, 252-3 PMID: 8174191
  71. Transient pulmonary hypertension from the intravenous injection of crushed, suspended pentazocine tablets.
    Chest. 1981 Aug;80(2):178-82 PMID: 7249763
  72. The lung physician and the antiphospholipid syndrome.
    Eur Respir J. 1997 Mar;10(3):511-2 PMID: 9072975
  73. Serotonin and acute cardiovascular disorders.
    Cardiovasc Drugs Ther. 1990 Jan;4 Suppl 1:19-25 PMID: 2285646
  74. Intravascular coagulation associated with the adult respiratory distress syndrome.
    Am J Med. 1976 Nov;61(5):585-9 PMID: 984062
  75. Acute hemodynamic response to the S2-serotonergic receptor antagonist, ketanserin, in patients with primary pulmonary hypertension.
    Int J Cardiol. 1987 Mar;14(3):303-9 PMID: 3557709
  76. Pulmonary manifestations of the collagen vascular diseases.
    Clin Chest Med. 1989 Dec;10(4):677-722 PMID: 2689071
  77. Cell signalling in pulmonary vascular cells: do not shoot the messenger!
    Thorax. 1996 Aug;51(8):864-6 PMID: 8795681
  78. Mitogenic effect of serotonin on vascular endothelial cells.
    Circulation. 1994 Oct;90(4):1919-26 PMID: 7923680
  79. The role of platelets in the adult respiratory distress syndrome. Culprits or bystanders?
    Am Rev Respir Dis. 1987 Feb;135(2):482-92 PMID: 3813208
  80. Pulmonary hypertension in chronic liver disease.
    Clin Chest Med. 1996 Mar;17(1):17-33 PMID: 8665788
  81. Ketanserin treatment and serotonin in patients with primary and secondary Raynaud's phenomenon.
    Eur J Clin Pharmacol. 1988;35(4):419-21 PMID: 3197751
  82. Serotonin syndrome. A clinical update.
    Crit Care Clin. 1997 Oct;13(4):763-83 PMID: 9330840
  83. Increased turnover of serotonin in children with pulmonary hypertension secondary to congenital heart disease.
    Pediatr Cardiol. 1996 Jul-Aug;17(4):214-9 PMID: 8662042
  84. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine.
    J Clin Invest. 1984 Sep;74(3):828-33 PMID: 6470141
  85. Vasodilator therapy for primary pulmonary hypertension.
    Mayo Clin Proc. 1984 Oct;59(10):672-7 PMID: 6148467
  86. Pulmonary hypertension.
    Curr Probl Cardiol. 1981 Jan;5(10):1-39 PMID: 7018843
  87. Hypoxic pulmonary hypertension: changes in platelet size and number.
    Am J Perinatol. 1991 Sep;8(5):300-3 PMID: 1760062
  88. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography.
    Circulation. 1995 Aug 15;92(4):790-5 PMID: 7641358
  89. Serotonin-induced pulmonary responses are mediated by the 5-HT2 receptor in the mouse.
    J Pharmacol Exp Ther. 1994 Jan;268(1):104-9 PMID: 8301545
  90. Platelet serotonin in systemic sclerosis.
    Ann Rheum Dis. 1989 Jul;48(7):586-9 PMID: 2774700
  91. Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism.
    Ann Surg. 1983 Feb;197(2):220-5 PMID: 6824376
  92. Nonatheromatous arterial thrombosis.
    Annu Rev Med. 1993;44:155-70 PMID: 8476237
  93. The role of endothelium in hypoxic constriction of human pulmonary artery rings.
    Am Rev Respir Dis. 1993 Feb;147(2):283-90 PMID: 8430949
  94. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia.
    Am J Physiol. 1988 Nov;255(5 Pt 2):H1165-72 PMID: 3189578
  95. Relationship of increased lung serotonin levels to endotoxin-induced pulmonary hypertension in sheep. Effect of a serotonin antagonist.
    Am Rev Respir Dis. 1985 Dec;132(6):1257-61 PMID: 2934013
  96. Increased plasma serotonin in primary pulmonary hypertension.
    Am J Med. 1995 Sep;99(3):249-54 PMID: 7653484
  97. Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: a preliminary report.
    Am J Med. 1995 Oct;99(4):392-6 PMID: 7573095
  98. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects.
    Oncol Res. 1997;9(2):55-60 PMID: 9167186
  99. The relationship of thrombocytopenia to the onset of persistent pulmonary hypertension of the newborn in the meconium aspiration syndrome.
    N Y State J Med. 1985 Jun;85(6):245-7 PMID: 3860753
  100. Prevalence of pulmonary hypertension in limited and diffuse scleroderma.
    Chest. 1996 Dec;110(6):1515-9 PMID: 8989070
  101. Ketanserin in the treatment of protamine-induced pulmonary hypertension.
    Tex Heart Inst J. 1996;23(4):301-4 PMID: 8969033
  102. Role of 5-hydroxytryptamine in endotoxin-induced respiratory failure of pigs.
    Am Rev Respir Dis. 1987 Jan;135(1):93-9 PMID: 3541719
  103. Platelet function in acute respiratory failure.
    Am J Hematol. 1987 Aug;25(4):377-88 PMID: 2956879
  104. Investigational approaches to pulmonary hypertension.
    Toxicol Pathol. 1991;19(4 Pt 1):458-69 PMID: 1813989
  105. Platelet imaging of thromboembolism. Natural history of postoperative deep venous thrombosis and pulmonary embolism illustrated using the 111In-labelled platelet-specific monoclonal antibody, P256.
    Chest. 1992 Jun;101(6):1597-600 PMID: 1600778
  106. Radiation-induced changes in the profile of spinal cord serotonin, prostaglandin synthesis, and vascular permeability.
    Int J Radiat Oncol Biol Phys. 1995 Jan 1;31(1):57-64 PMID: 7527800
  107. Pharmacology of serotonin as related to anesthesia.
    J Clin Anesth. 1996 Aug;8(5):402-25 PMID: 8832453
  108. Effects of serotonin on the cardiopulmonary circulatory system with and without 5-HT2-receptor blockade by ketanserin.
    J Cardiovasc Pharmacol. 1985;7 Suppl 7:S64-6 PMID: 2412062
  109. Prognostic significance of plasma D-dimer levels in patients with lung cancer.
    Thorax. 1997 Jun;52(6):563-5 PMID: 9227726
  110. Persistent pulmonary hypertension after lithium intoxication in the newborn.
    Eur J Pediatr. 1982 Jul;138(4):321-3 PMID: 7128640
  111. Nitric oxide synthase: role in the genesis of vascular disease.
    Annu Rev Med. 1997;48:489-509 PMID: 9046979
  112. Valvular heart disease associated with fenfluramine-phentermine.
    N Engl J Med. 1997 Aug 28;337(9):581-8 PMID: 9271479
  113. [Serotonin metabolism and pulmonary hypertension in chronic lung diseases].
    Sov Med. 1976 Dec;(12):107-11 PMID: 1013779
  114. Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria.
    Chest. 1992 Aug;102(2):642-3 PMID: 1643968
  115. The pulmonary vascular lesions of the adult respiratory distress syndrome.
    Am J Pathol. 1983 Jul;112(1):112-26 PMID: 6859225
  116. Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids.
    Surgery. 1981 Oct;90(4):720-8 PMID: 7281010
  117. Increased pulmonary artery elastolytic activity in adult rats with monocrotaline-induced progressive hypertensive pulmonary vascular disease compared with infant rats with nonprogressive disease.
    Am Rev Respir Dis. 1992 Jul;146(1):213-23 PMID: 1626806
  118. Paroxysmal nocturnal haemoglobinuria in pregnancy: case report.
    Br J Obstet Gynaecol. 1980 Mar;87(3):246-8 PMID: 7387930
  119. Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
    Br J Pharmacol. 1984 Jun;82(2):375-80 PMID: 6234044
  120. The extraction of circulating catecholamines by the lungs in normal man and in patients with pulmonary hypertension.
    Circulation. 1979 Jul;60(1):160-3 PMID: 445719
  121. [Pulmonary vasoconstrictor responses].
    Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Dec;30 Suppl:15-25 PMID: 1363972
  122. Role of 5-hydroxytryptamine in the progression of monocrotaline induced pulmonary hypertension in rats.
    Cardiovasc Res. 1993 Sep;27(9):1619-23 PMID: 8287439
  123. Pulmonary disease associated with L-tryptophan-induced eosinophilic myalgia syndrome. Clinical and pathologic features.
    Chest. 1990 May;97(5):1032-6 PMID: 2331898
  124. Pulmonary neuroendocrine cells. Their secretory products and their potential roles in health and chronic lung disease in infancy.
    Am Rev Respir Dis. 1989 Dec;140(6):1807-12 PMID: 2574971
  125. Pulmonary hypertensive diseases.
    Chest. 1984 Mar;85(3):397-405 PMID: 6365477
  126. Metabolic functions of the lung. Of what clinical relevance?
    Chest. 1982 Feb;81(2):215-23 PMID: 6276106
  127. Pulmonary artery atherosclerosis: correlation with systemic atherosclerosis and hypertensive pulmonary vascular disease.
    Arch Pathol Lab Med. 1982 Aug;106(8):378-80 PMID: 6213213
  128. Acute hemodynamic effects of ketanserin in pulmonary hypertension secondary to systemic sclerosis.
    J Rheumatol. 1987 Jun;14(3):519-24 PMID: 3625632
  129. Structure and function in pulmonary hypertension. New perceptions.
    Chest. 1986 Feb;89(2):279-88 PMID: 3510824
  130. Comparative effects of oxygen, nifedipine and ketanserin in hypoxic pulmonary hypertension.
    Cor Vasa. 1985;27(6):406-11 PMID: 2936568
  131. Humoral factors in massive pulmonary embolism: an experimental study.
    Am Heart J. 1968 Dec;76(6):784-94 PMID: 5721836
  132. Effects of dipyridamole on the hypoxemic pulmonary hypertension of patients with chronic obstructive pulmonary disease.
    Respiration. 1988;53(1):13-9 PMID: 3387686
  133. Mechanisms and pathology of monocrotaline pulmonary toxicity.
    Crit Rev Toxicol. 1992;22(5-6):307-25 PMID: 1489509
  134. Ultrastructural injury of arterial endothelium. II. Effects of vasoactive amines.
    Arch Pathol. 1969 Aug;88(2):106-12 PMID: 4307433
  135. Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature.
    Arch Pathol Lab Med. 1990 Jan;114(1):62-4 PMID: 2403780
  136. Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echocardiographic study of 135 Japanese patients.
    Chest. 1997 Jan;111(1):36-43 PMID: 8995990
  137. Mechanisms of hypoxic pulmonary vasoconstriction.
    Am Rev Respir Dis. 1986 Jun;133(6):1186-95 PMID: 3334415
  138. Platelet aggregation in patients with primary pulmonary hypertension.
    Blood Coagul Fibrinolysis. 1996 Mar;7(2):225-7 PMID: 8735825
  139. Reflex pulmonary hypertension and systemic hypotension after microsphere pulmonary embolism: a myth.
    Am J Surg. 1969 Dec;118(6):925-30 PMID: 5358903
  140. Florid vascular proliferation associated with neural and neuroendocrine neoplasms. A diagnostic clue and potential pitfall.
    Am J Surg Pathol. 1995 Jun;19(6):642-52 PMID: 7538732
  141. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics.
    Gastroenterology. 1991 Feb;100(2):520-8 PMID: 1985048
  142. Early radiation response of the canine heart and lung.
    Radiat Res. 1991 Jan;125(1):34-40 PMID: 1986399
  143. Lung serotonin metabolism.
    Clin Chest Med. 1989 Mar;10(1):59-70 PMID: 2650964
  144. Pretransplant clinicopathological correlation in end-stage primary pulmonary hypertension.
    Eur Respir J. 1994 Apr;7(4):672-8 PMID: 8005247
  145. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.
    Am J Pathol. 1994 Feb;144(2):275-85 PMID: 7508683
  146. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection.
    Hum Pathol. 1997 Apr;28(4):434-42 PMID: 9104943
  147. Role of pulmonary intravascular macrophages in anti-platelet serum-induced pulmonary hypertension in sheep.
    Respir Physiol. 1994 Sep;98(1):83-99 PMID: 7817044
  148. Droperidol prevents serotonin-induced bronchospasm, pulmonary hypertension, and intrapulmonary shunt.
    Anesth Analg. 1992 Feb;74(2):316 PMID: 1731564
  149. Platelet count and venous thromboembolism. A useful test for suspected pulmonary embolism.
    Chest. 1991 Dec;100(6):1493-6 PMID: 1959389
  150. Platelets and the puzzles of pulmonary pyrrolizidine poisoning.
    Toxicol Appl Pharmacol. 1988 May;93(3):463-71 PMID: 3130680
  151. Biogenic amines derived from tryptophan in systemic and cutaneous scleroderma.
    Acta Derm Venereol. 1979;59(1):1-5 PMID: 84460
  152. The role of serotonin in experimental pulmonary embolism.
    Surg Gynecol Obstet. 1955 Dec;101(6):691-700 PMID: 13274276
  153. Platelet activation mechanisms and markers in arterial thrombosis.
    J Intern Med. 1996 Jan;239(1):17-34 PMID: 8551196
  154. Evidence for local platelet activation in pulmonary vessels in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease.
    Eur Respir J. 1991 Feb;4(2):147-51 PMID: 1828437
  155. The role of thrombosis in severe pulmonary hypertension.
    Eur Respir J. 1996 Feb;9(2):356-63 PMID: 8777977
  156. Asbestos-induced fibrosis in rats: increase in lung mast cells and autacoid contents.
    Exp Lung Res. 1987;13(3):311-27 PMID: 2446859
  157. [Pulmonary hemodynamics and serotonin level in patients with chronic pneumonia with arterial hypertension].
    Vrach Delo. 1985 Dec;(12):33-5 PMID: 4095954
  158. Anti-platelet agents reduce morphological changes of chronic hypoxic pulmonary hypertension.
    Histol Histopathol. 1987 Apr;2(2):203-6 PMID: 2980720
  159. Genetic determinants of pulmonary hypertension in fawn-hooded rats.
    Chest. 1997 Jun;111(6 Suppl):96S PMID: 9184548
  160. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis.
    Circulation. 1994 Jun;89(6):2525-32 PMID: 8205660
  161. Pulmonary arterial hypertension in portal hypertension.
    Clin Gastroenterol. 1985 Jan;14(1):123-38 PMID: 3987074
  162. Inhibitory effect of heparin on serotonin-induced hyperplasia and hypertrophy of smooth muscle cells.
    Am J Respir Cell Mol Biol. 1997 Jul;17(1):78-83 PMID: 9224212
  163. Ketanserin in the treatment of pulmonary hypertension after valvular surgery: a comparison with sodium nitroprusside.
    Crit Care Med. 1989 Jul;17(7):613-8 PMID: 2736920
  164. On the role of serotonin in the pathogenesis of pulmonary hypertension induced by anorectic drugs; an experimental study in the isolated perfused rat lung, II. Fenfluramine, mazindol, mefenorex, phentermine and R 800.
    Clin Exp Pharmacol Physiol. 1976 Jul-Aug;3(4):323-30 PMID: 975621
  165. Reflex and direct cardiopulmonary effects of 5-OH-tryptamine (serotonin); their possible role in pulmonary embolism and coronary thrombosis.
    Am J Physiol. 1953 Jun;173(3):379-86 PMID: 13065459
  166. Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects.
    Circulation. 1987 Nov;76(5):1043-52 PMID: 3117409
  167. Release of platelet 5-hydroxytryptamine by some anorexic and other sympathomimetics and their acetyl derivatives.
    Acta Pharmacol Toxicol (Copenh). 1977 Sep;41(3):218-24 PMID: 578650
  168. [Role of serotonin in impaired gas exchange during pulmonary embolism].
    Nihon Kyobu Shikkan Gakkai Zasshi. 1995 Sep;33(9):947-55 PMID: 8538090
  169. Gap junction function in vascular smooth muscle: influence of serotonin.
    Am J Physiol. 1995 Oct;269(4 Pt 2):H1481-9 PMID: 7485584
  170. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.
    N Engl J Med. 1996 Aug 29;335(9):609-16 PMID: 8692238
  171. Comparison of the haemodynamic effects of dopamine and dobutamine in young children undergoing cardiac surgery.
    Br J Anaesth. 1995 Apr;74(4):419-23 PMID: 7734262
  172. Bleeding and thrombosis in the myeloproliferative disorders.
    Blood. 1984 Jul;64(1):1-12 PMID: 6375757
  173. Pulmonary vascular response to live Escherichia coli: influences of different antiplatelet substances.
    Circ Shock. 1987;22(2):173-83 PMID: 3297380
Article Info
Journal
Thorax
Abbr.
Thorax
ISSN
0040-6376
DOI
10.1136/thx.54.2.161
Published
1999-02-00
Pages
161-8
Language
English
Region
England
NLM ID
0417353
PMCID
PMC1745408
Subset
IM
External Links
PubMed source DOI: 10.1136/thx.54.2.161 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2